Welcome to our dedicated page for Centene Del news (Ticker: CNC), a resource for investors and traders seeking the latest updates and insights on Centene Del stock.
Centene Corporation reports news on its government-sponsored managed care business, including Medicaid, Medicare, individual exchange coverage and Medicare Part D plans. Company updates commonly cover quarterly results, EPS guidance, membership by line of business and health-plan subsidiary activity across state markets.
Centene news also includes initiatives from the Centene Foundation and operating companies such as Health Net, Superior HealthPlan, Home State Health, Sunshine Health, Buckeye Health Plan, Carolina Complete Health and WellCare of Kentucky. Recurring themes include affordable housing, medically tailored meals, provider accessibility, workforce development, community health, social services and programs that address drivers of health for managed care members.
Centene Corporation (NYSE: CNC) has signed a definitive agreement to acquire Apixio Inc., a healthcare analytics company specializing in AI technology solutions. This transaction, subject to regulatory approval, is expected to conclude by the end of 2020. Apixio's technology analyzes unstructured patient data to enhance healthcare administration, aligning with Centene's goal to modernize healthcare services. The acquisition aims to create synergies with Centene's existing data analytics products, supporting value-based healthcare delivery.
Centene Corporation (NYSE: CNC) will attend two virtual conferences this November. The first is the Credit Suisse 29th Annual Healthcare Conference on November 10 at 8:45 a.m. EST, with a live audio webcast available here.
The second conference is the Bernstein Operational Decisions Conference on November 16 at 8:00 a.m. EST, with details accessible here. Webcast replays will be available on Centene's website.
Centene Corporation (NYSE: CNC) released its Q3 2020 financial results, reporting total revenues of $29.1 billion, a 53% increase from the previous year. Diluted EPS stood at $0.97, adjusted EPS at $1.26, boosted by a $398 million ACA risk corridor settlement. Managed care membership rose 65% YoY to 25.2 million. Operating cash flow was $(952) million, primarily due to health insurer fees. The company also issued $2.2 billion in senior notes to refinance existing debt and anticipates continued growth in various markets, with an adjusted EPS guidance of $4.90 to $5.06 for 2020.
Health Net Federal Services, a subsidiary of Centene Corporation (NYSE: CNC), has achieved URAC Health Network Accreditation, reinforcing its commitment to quality care and improved outcomes. This accreditation, effective from July 1, 2020, to July 1, 2023, marks a continuous achievement since 2005. URAC's rigorous standards ensure high-quality service for the military community, supporting nearly 2.9 million beneficiaries through the TRICARE program. This status highlights Health Net's dedication to providing reliable and cost-effective healthcare solutions.
Centene Corporation (NYSE: CNC) announced an expansion of its Medicare Advantage offerings for 2021, increasing its services to 1,249 counties across 33 states, a 30% rise from 2020. The company introduces 122 new plan designs, including Medicare plans in Vermont and Rhode Island. Centene aims to provide affordable, high-quality options to nearly 1 million Medicare members during the ongoing challenges of COVID-19. Centene emphasizes its commitment to enhancing member health and well-being with new benefits and solutions.
Centene Corporation (NYSE: CNC) has priced its public offering of $2.2 billion in 3.00% senior notes due 2030. The offering is expected to close around October 7, 2020. The net proceeds will primarily be used to redeem existing senior notes, including 4.75% notes due 2022 and 5.25% notes due 2025, along with related costs. The senior notes will be unsecured and rank equally with the company’s existing senior debt, but will not be guaranteed by any subsidiaries.
Centene Corporation (NYSE: CNC) has launched a public offering for $2.2 billion in senior notes due 2030. The funds will be used to redeem its outstanding 4.75% Senior Notes due 2022 and 5.25% Senior Notes due 2025, including those from its subsidiary, WellCare Health Plans, Inc. The company plans to temporarily utilize net proceeds for general corporate purposes until the redemptions are completed. The offering is managed by major financial institutions including BofA Securities and J.P. Morgan.
Centene Corporation (NYSE: CNC) plans to release its 2020 third-quarter financial results on October 27, 2020, at 6 a.m. Eastern Time. Following the release, a conference call will be held at 8:30 a.m. Eastern Time, hosted by CEO Michael F. Neidorff and CFO Jeffrey A. Schwaneke. Investors can join the call by dialing the provided numbers or via a live audio webcast on the company's website. A replay will be available for up to one year after the call. Centene focuses on providing integrated healthcare services to under-insured populations and has a strong commitment to local healthcare solutions.
Centene Corporation (NYSE: CNC) collaborates with Samsung Electronics America to enhance telehealth access for rural and underserved communities. The program involves distributing 13,000 Galaxy A10e smartphones, including 90 days of free service, to around 200 federally qualified health centers (FQHCs) and community organizations. This initiative aims to address the increased demand for virtual healthcare due to COVID-19, where a CDC survey indicated that 44.4% of individuals delayed care. Centene's CEO emphasizes the importance of telehealth in improving healthcare access during these times.
Centene Corporation (NYSE: CNC) plans to significantly expand its Ambetter health insurance products in the 2021 Health Insurance Marketplace. The expansion targets nearly 400 new counties across 13 existing states and introduces Ambetter in two new states: New Mexico and Michigan, increasing its presence to 22 states. Serving around 2.2 million exchange members in 2020, Centene emphasizes offering affordable healthcare options amidst the COVID-19 pandemic while seeking regulatory approvals for the upcoming expansion.